Glycominds international is an innovative diagnostics company that specializes in gastrointestinal disease management. As a leading groundbreaker in microbiome biomarker research, Glycominds offers the only validated serum biomarker tests on the market for Inflammatory Bowel Disease (IBD). Their proprietary technology platform provides physicians with accurate and non-invasive diagnostic solutions, allowing patients to have personalized control over their diagnosis and disease progression.

With a focus on Crohn’s Disease and Ulcerative Colitis, Glycominds' biomarkers help identify patients who have Inflammatory Bowel Diseases, predict higher risk for complicated disease, and monitor Anti-TNF therapy response. Their products include diagnostic reagents in the USA and diagnostic kits internationally. Glycominds' dedication to advancing IBD diagnostics is recognized by organizations such as the Crohn's & Colitis Foundation.

For more information about their services, you can contact Glycominds via phone at +1 866. 532. 5364 or email at office@glycominds.

com. Discover the future of personalized gastrointestinal disease management with Glycominds